THE EFFECTS OF GINSENOSIDE Rg1 ON CHRONIC STRESS INDUCED DEPRESSION-LIKE BEHAVIORS, BDNF EXPRESSION AND THE PHOSPHORYLATION OF PKA AND CREB IN RATS
THE EFFECTS OF GINSENOSIDE Rg1 ON CHRONIC STRESS INDUCED DEPRESSION-LIKE BEHAVIORS, BDNF EXPRESSION AND THE PHOSPHORYLATION OF PKA AND CREB IN RATS
复制标题
人参皂苷Rg1对慢性应激大鼠抑郁样行为、BDNF表达及PKA、CREB磷酸化的影响
DOI：
10.1016/j.neuroscience.2016.02.050
复制
发表时间：
2016-05-13
期刊：
影响因子：
3.3
通讯作者：
Yu, S. Y.
中科院分区：
文献类型：
--
作者：
Liu, Z.;Qi, Y.;Yu, S. Y.
Depression is a common neuropsychiatric disorder which has been associated with a wide range of structural and functional changes within specific brain regions. Ginsenoside Rg1 has been shown to exert a number of neuroprotective effects as demonstrated in various in vivo and in vitro studies. However, little information is available regarding the site and mechanisms of ginsenoside Rg1 in promoting antidepressant effects. The present study aimed to investigate the neuroprotective and ameliorating effects of ginsenoside Rg1 on depression-like behavior as induced by chronic unpredictable mild stress (CUMS). The results showed that CUMS was effective in producing depression-like behaviors in rats as indicated by decreased responses in sucrose preference and forced swim tests which were associated with ultrastructural changes in neurons within the amygdala. Moreover, levels of PKA and CREB phosphorylation and the expression of brain-derived neurotrophic factor (BDNF) were decreased in the amygdala of CUMS rats. Remarkably, chronic ginsenoside Rg1 (40 mg/kg, i.p., 5 weeks) treatment significantly ameliorated these behavioral and biochemical alterations associated with CUMS-induced depression. Taken together, the results of the present study demonstrate that ginsenoside Rg1 exhibits antidepressant-like effects against CUMS-induced depression. This amelioration of depression-like behaviors by ginsenoside Rg1 appears to be mediated, at least in part, by a CREB-regulated increase of BDNF expression in the amygdala of rats. Therefore, these findings reveal the therapeutic potential of ginsenoside Rg1 for use in clinical trials in the treatment of depression. (C) 2016 IBRO. Published by Elsevier Ltd. All rights reserved.
